Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Change in Accured Expenses of $958000.0 for Q3 2025, up 333.48% year-over-year from $221000.0 in Q3 2024, and up 4065.22% quarter-over-quarter from $23000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Change in Accured Expenses for 16 consecutive years, with $958000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Change in Accured Expenses rose 333.48% year-over-year to $958000.0; the TTM figure through Sep 2025 stood at $2.6 million (up 724.76% YoY), while the FY2024 annual figure was -$2.9 million, down 176.95% from the prior year.
- Change in Accured Expenses rose to $958000.0 in Q3 2025 per XTNT's latest filing, from $23000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.7 million in Q1 2025 and bottomed at -$1.6 million in Q3 2021.
- Historically, Change in Accured Expenses has averaged $243526.3 across 5 years, with a median of $221000.0 in 2024.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses surged 10636.36% — and 2024, when it slumped 788.78%.
- Xtant Medical Holdings' Change in Accured Expenses stood at $270000.0 in 2021, then surged by 75.93% to $475000.0 in 2022, then soared by 198.74% to $1.4 million in 2023, then plunged by 175.55% to -$1.1 million in 2024, then surged by 189.37% to $958000.0 in 2025.
- Business Quant data shows XTNT's Change in Accured Expenses at $958000.0 in Q3 2025, $23000.0 in Q2 2025, and $2.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Xtant Medical Holdings | 46.72 Mn | 29.11 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 958,000.00 |
| Sep 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | 221,000.00 |
| Sep 30, 2024 | 221,000.00 |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -675,000.00 |
| Mar 31, 2024 | -675,000.00 |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 660,000.00 |
| Jun 30, 2023 | 660,000.00 |